| In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for … C Adamichou, D Nikolopoulos, I Genitsaridi, A Bortoluzzi, A Fanouriakis, ... Annals of the rheumatic diseases 79 (2), 232-241, 2020 | 97 | 2020 |
| Cardiovascular disease in systemic lupus erythematosus: recent data on epidemiology, risk factors and prevention M Kostopoulou, D Nikolopoulos, I Parodis, G Bertsias Current Vascular Pharmacology 18 (6), 549-565, 2020 | 96 | 2020 |
| Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus C Adamichou, I Genitsaridi, D Nikolopoulos, M Nikoloudaki, A Repa, ... Annals of the rheumatic diseases 80 (6), 758-766, 2021 | 75 | 2021 |
| Transcriptome reprogramming and myeloid skewing in haematopoietic stem and progenitor cells in systemic lupus erythematosus M Grigoriou, A Banos, A Filia, P Pavlidis, S Giannouli, V Karali, ... Annals of the rheumatic diseases 79 (2), 242-253, 2020 | 70 | 2020 |
| Cerebrovascular Events in Systemic Lupus Erythematosus: Diagnosis and Management D Nikolopoulos, A Fanouriakis, DT Boumpas MEDITERRANEAN JOURNAL OF RHEUMATOLOGY 1 (30), 7-15, 2019 | 53 | 2019 |
| Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset … D Nikolopoulos, M Kostopoulou, A Pieta, T Karageorgas, D Tseronis, ... Lupus 29 (5), 514-522, 2020 | 51 | 2020 |
| Update on the pathogenesis of central nervous system lupus D Nikolopoulos, A Fanouriakis, DT Boumpas Current Opinion in Rheumatology 31 (6), 669-677, 2019 | 32 | 2019 |
| Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease DS Nikolopoulos, M Kostopoulou, A Pieta, S Flouda, K Chavatza, ... Lupus Science & Medicine 7 (1), e000394, 2020 | 30 | 2020 |
| Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients K Chavatza, M Kostopoulou, D Nikolopoulos, O Gioti, K Togia, L Andreoli, ... Annals of the rheumatic diseases 80 (9), 1175-1182, 2021 | 21 | 2021 |
| Treatment of neuropsychiatric systemic lupus erythematosus: clinical challenges and future perspectives D Nikolopoulos, A Fanouriakis, G Bertsias Expert Review of Clinical Immunology 17 (4), 317-329, 2021 | 19 | 2021 |
| Microglia activation in the presence of intact blood–brain barrier and disruption of hippocampal neurogenesis via IL-6 and IL-18 mediate early diffuse neuropsychiatric lupus D Nikolopoulos, T Manolakou, A Polissidis, A Filia, G Bertsias, ... Annals of the Rheumatic Diseases 82 (5), 646-657, 2023 | 18 | 2023 |
| Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: a multi-center observational study S Yavuz, DU Cansu, D Nikolopoulos, F Crisafulli, AM Antunes, ... Seminars in arthritis and rheumatism 50 (6), 1387-1393, 2020 | 18 | 2020 |
| The role of plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis I Bellos, I Michelakis, D Nikolopoulos Clinical Rheumatology 40, 1447-1456, 2021 | 15 | 2021 |
| From first symptoms to diagnosis of systemic lupus erythematosus: mapping the journey of patients in an observational study NN Kapsala, DS Nikolopoulos, SP Flouda, AP Chavatza, DD Tseronis, ... Clin Exp Rheumatol 41 (1), 74-81, 2023 | 13 | 2023 |
| ATR-mediated DNA damage responses underlie aberrant B cell activity in systemic lupus erythematosus T Manolakou, D Nikolopoulos, D Gkikas, A Filia, M Samiotaki, ... Science Advances 8 (43), eabo5840, 2022 | 13 | 2022 |
| Cross-species transcriptome analysis for early detection and specific therapeutic targeting of human lupus nephritis E Frangou, P Garantziotis, M Grigoriou, A Banos, D Nikolopoulos, A Pieta, ... Annals of the Rheumatic Diseases 81 (10), 1409-1419, 2022 | 13 | 2022 |
| Demyelinating syndromes in systemic lupus erythematosus: data from the “Attikon” lupus cohort D Nikolopoulos, D Kitsos, M Papathanasiou, N Kapsala, P Garantziotis, ... Frontiers in Neurology 13, 889613, 2022 | 13 | 2022 |
| Interstitial Pneumonia with Autoimmune Features (IPAF): A Single-Centre, Prospective Study TK Maria Karampeli, Konstantinos Thomas, Sofia Flouda, Aikaterina Chavatza ... Mediterranean Journal of Rheumatology 31 (3), 330-6, 2020 | 12 | 2020 |
| Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study M Nikoloudaki, D Nikolopoulos, S Koutsoviti, I Flouri, N Kapsala, A Repa, ... Frontiers in Immunology 13, 1074044, 2023 | 11 | 2023 |
| Remission or low disease activity at pregnancy onset are linked to improved foetal outcomes in women with systemic lupus erythematosus: results from a prospective observational … S Ntali, D Nikolopoulos, L Pantazi, E Emmanouilidou, C Papagoras, ... Clin Exp Rheumatol 40 (9), 1769-78, 2022 | 10 | 2022 |
